Ahn-Gook Pharmaceutical Co. Ltd (001540) — Cash Flow-to-Debt Ratio
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of ₩14.44 Billion could theoretically repay 0% of its total liabilities (₩136.13 Billion) in one year. See Ahn-Gook Pharmaceutical Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ahn-Gook Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Ahn-Gook Pharmaceutical Co. Ltd across 13 annual periods. Also explore net asset growth rate of Ahn-Gook Pharmaceutical Co. Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year debt coverage analysis for Ahn-Gook Pharmaceutical Co. Ltd. For market capitalisation and broader financial context, see Ahn-Gook Pharmaceutical Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | ₩4.91 Billion | ₩136.86 Billion | ▲ +335.1% |
| 2023 | -0.02x | ₩-1.33 Billion | ₩86.93 Billion | ▼ -159.0% |
| 2022 | 0.03x | ₩1.79 Billion | ₩69.11 Billion | ▲ +17.0% |
| 2021 | 0.02x | ₩1.47 Billion | ₩66.54 Billion | ▼ -88.6% |
| 2020 | 0.19x | ₩11.19 Billion | ₩57.60 Billion | ▼ -38.7% |
| 2019 | 0.32x | ₩22.08 Billion | ₩69.71 Billion | ▲ +1844.4% |
| 2018 | -0.02x | ₩-1.20 Billion | ₩66.16 Billion | ▼ -107.4% |
| 2017 | 0.25x | ₩17.46 Billion | ₩71.11 Billion | ▲ +27.2% |
| 2016 | 0.19x | ₩12.62 Billion | ₩65.37 Billion | ▼ -32.5% |
| 2015 | 0.29x | ₩19.11 Billion | ₩66.79 Billion | ▲ +1158.7% |
| 2014 | 0.02x | ₩1.29 Billion | ₩56.61 Billion | ▼ -77.0% |
| 2013 | 0.10x | ₩3.64 Billion | ₩36.82 Billion | ▼ -54.1% |
| 2012 | 0.22x | ₩11.51 Billion | ₩53.47 Billion | — |